| Nanomedicines in Tuberculosis: Diagnosis, Therapy and Nanodrug Delivery | Abdel Naser Dakkah, Yazan Bataineh, Bilal A AL Jaidi, Mohammad F. Bayan and Nabil A. Nimer | ---- | 1 | 257-405 | Springer | Integrative Nanomedicine for New Therapies | 2020 |
| Biomaterials and Nanoparticles for Hyperthermia Therapy | Pran Kishore Deb, Haifa’a Marouf Abdellatif Odetallah, Bilal Al-Jaidi, Raghuram Rao Akkinepalli, Amal Al-Aboudi, Rakesh K. Tekade | ---- | 1 | 375-413 | Elsevier | BIOMATERIALS AND BIONANOTECHNOLOGY | 2019 |
| Drug-Receptor Interactions | Balakumar Chandrasekaran, Haneen Al-Joubi, Sara Samarneh, Ghadir Kassab, Pran Kishore Deb, Puneet Kumar, Bilal A. Al-Jaidi, Yazan Al-Thaher, and Yazan A. Bataineh | ---- | 1 | 31-68 | Springer | Frontiers in Pharmacology of Neurotransmitters | 2020-11-10 00:00:00 |
| Neuropeptides and Neurotransmission | Anindita Mondal Gantait, Yazan A. Bataineh, Hiba Salim Surchi, Arunava Gantait, G. Tulja Rani, Paramita Paul, Sarah Falah Kokaz, Bilal A. Al-Jaidi, Puneet Kumar, Saumen Karan, and Tanushree Singha | ---- | 1 | 553-578 | Springer | Frontiers in Pharmacology of Neurotransmitters | 2020-11-10 00:00:00 |
| Molecular Basis of Binding Interactions of NSAIDs and Computer-Aided Drug Design Approaches in the Pursuit of the Development of Cyclooxygenase-2 (COX-2) Selective Inhibitors | Pran Kishore Deb, Raghu Prasad Mailabaram, Bilal Al-Jaidi and Mohamed Jamal Saadh | ---- | 1 | 100-121 | IntechOpen | Nonsteroidal Anti-Inflammatory Drugs | 2017 |